<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Licensed vaccines such as BCG and oral polio vaccine have been shown to have nonspecific, modulatory effects on the immune system and provide protection against other infectious diseases 
 <xref rid="b0300" ref-type="bibr">[60]</xref>, 
 <xref rid="b0305" ref-type="bibr">[61]</xref>, 
 <xref rid="b0310" ref-type="bibr">[62]</xref>, 
 <xref rid="b0315" ref-type="bibr">[63]</xref>, 
 <xref rid="b0320" ref-type="bibr">[64]</xref>. This has led to the suggestion that these vaccines may have an effect in the prevention of COVID-19 
 <xref rid="b0325" ref-type="bibr">[65]</xref>. Three multi-centred randomised controlled trials on BCG vaccine administration are underway in health care workers in Australia 
 <xref rid="b0330" ref-type="bibr">[66]</xref>, Netherlands 
 <xref rid="b0335" ref-type="bibr">[67]</xref> and South Africa 
 <xref rid="b0340" ref-type="bibr">[68]</xref>. A measles vaccine trial to prevent COVID-19 in health care workers in Egypt has been registered 
 <xref rid="b0290" ref-type="bibr">[58]</xref> and oral polio vaccines are being considered in the United States of America 
 <xref rid="b0345" ref-type="bibr">[69]</xref>.
</p>
